WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001034600) PROTEASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/034600    International Application No.:    PCT/US2000/030757
Publication Date: 17.05.2001 International Filing Date: 08.11.2000
Chapter 2 Demand Filed:    17.05.2001    
IPC:
A61K 31/55 (2006.01), C07D 401/14 (2006.01)
Applicants: SMITHKLINE BEECHAM CORPORATION [US/US]; One Franklin Plaza, Philadelphia, PA 19103 (US) (For All Designated States Except US).
MARQUIS, Robert, Wells, Jr. [US/US]; (US) (For US Only).
VEBER, Daniel, Frank [US/US]; (US) (For US Only)
Inventors: MARQUIS, Robert, Wells, Jr.; (US).
VEBER, Daniel, Frank; (US)
Agent: STERCHO, Yuriy, P.; SmithKline Beecham Corporation, Corporate Intellectual Property, UW2220, 709 Swedeland Road, P.O. Box 1539, King of Prussia, PA 19406-0939 (US)
Priority Data:
60/164,560 10.11.1999 US
Title (EN) PROTEASE INHIBITORS
(FR) INHIBITEURS DE PROTEASE
Abstract: front page image
(EN)The invention relates to the compound of Formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof, which is an inhibitor of cysteine proteases, particularly cathepsin K, and is useful in the treatment of diseases in which inhibition of loss or of cartilage degradation is a factor.
(FR)L'invention concerne le composé représenté par la formule (I) ou un sel, un hydrate ou un solvate pharmaceutiquement acceptables, qui est un inhibiteur des cystéines protéases, en particulier la cathepsine K. Ce composé est utile pour le traitement de maladies dans lesquelles l'inhibition de la perte osseuse ou de la dégradation des cartilages est un facteur.
Designated States: CA, JP, US.
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR).
Publication Language: English (EN)
Filing Language: English (EN)